英国多囊卵巢综合征发病率上升、健康资源利用与费用增加
该研究利用英国临床实践研究数据链Aurum和医院统计数据库,计算2004至2020年多囊卵巢综合征(PCOS)的时点患病率和发病率,并按年龄、体质指数和初级保健机构1:1匹配对照,比较医疗资源使用与费用。结果显示PCOS发病率从2004年1.22/1000人年升至2019年2.20/1000人年,患病率从1.02%升至3.5%,患者总医疗接触和总费用均显著高于对照。
要点
- PCOS发病率从2004年1.22/1000人年升至2019年2.20/1000人年。
- PCOS时点患病率从2004年1.02%升至2020年3.5%,亚洲人群最高。
- PCOS患者总医疗接触10.72次/人年 vs 对照7.11次/人年(P < .001)。
核心结论
- PCOS发病率显著上升,其健康资源利用和费用显著高于对照。
研究设计与样本
- 数据提取自英国临床实践研究数据链Aurum和医院统计数据库,计算2004至2020年的时点患病率和发病率。
- PCOS患者按年龄、体质指数和初级保健机构1:1匹配对照。
- 初级保健接触分配平均成本,处方项目分配净成分成本;住院和门诊就诊处理为医疗资源组并按国家收费标准计价。
主要发现
- PCOS发病率从2004年1.22/1000人年升至2012年1.77/1000人年和2019年2.20/1000人年。
- PCOS时点患病率从2004年1.02%升至2012年2.2%和2020年3.5%,亚洲人群最高。
- PCOS患者 vs 对照的平均接触次数/人年:住院0.48 vs 0.29(P < .001),门诊3.81 vs 2.15(P < .001),初级保健6.43 vs 4.68(P < .001)。
- PCOS患者 vs 对照的平均医疗费用/人年:住院£837 vs £493(P < .001),门诊£444 vs £253(P < .001),初级保健£157 vs £112,初级保健处方£109 vs £83(P < .001)。
- PCOS患者 vs 对照的总医疗接触/人年为10.72 vs 7.11(P < .001),总相关费用为£1546 vs £940(P < .001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Trends in incidence of polycystic ovary syndrome (PCOS) and effects on health resource utilization are unclear. OBJECTIVE: To describe trends in prevalence and incidence of PCOS in the United Kingdom. To establish healthcare resource use and associated costs. METHODS: Data were extracted from the Clinical Practice Research Datalink Aurum and Hospital Episode Statistics databases. Point prevalence and incidence were calculated (2004-2020). Patients with PCOS were matched to controls (1:1) by age, body mass index, and primary care practice. Primary care contacts were assigned an average cost and prescription items assigned a net ingredient cost. Inpatient admissions and outpatient consultations were processed into healthcare resource groups and costed to the national tariff. RESULTS: PCOS incidence increased from 1.22 per 1000 person years in 2004 to 1.77 (2012) and 2.20 (2019). Point prevalence increased from 1.02% (2004) to 2.2% (2012) and 3.5% (2020), and was highest in Asians. Mean contacts per person year (ppy) for patients with PCOS vs controls were 0.48 vs 0.29 for inpatients (P < .001), 3.81 vs 2.15 for outpatients (P < .001), and 6.43 vs 4.68 (P < .001) for primary care. Mean healthcare costs (ppy) were £837 vs £493 (P < .001) for inpatients, £444 vs £253 (P < .001) for outpatients, £157 vs £112 for primary care, and £109 vs £83 (P < .001) for primary care prescriptions. Total healthcare contacts ppy were 10.72 vs 7.11 (P < .001) and total associated costs £1546 vs £940 (P < .001). CONCLUSION: The incidence of PCOS has risen significantly. Health resource utilization and costs of PCOS are significantly greater than controls.
引用
- Berni TR, Morgan CL, Rees DA, et al. Rising Incidence, Health Resource Utilization, and Costs of Polycystic Ovary Syndrome in the United Kingdom. J Clin Endocrinol Metab. 2025. PMID: 39049776. doi:10.1210/clinem/dgae518
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。